FGFR1 amplification and the progression of non-invasive to invasive breast cancer

The incidence of invasive breast cancer (IBC) can be dramatically reduced by improving our abilities to detect and treat ductal carcinoma in situ (DCIS). Progress will be based on a detailed understanding of molecular mechanisms responsible for tumor progression. An interesting study by Jang and col...

Descripción completa

Detalles Bibliográficos
Autores principales: Gru, Alejandro A, Allred, D Craig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053127/
https://www.ncbi.nlm.nih.gov/pubmed/23151501
http://dx.doi.org/10.1186/bcr3340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053127/
https://www.ncbi.nlm.nih.gov/pubmed/23151501
http://dx.doi.org/10.1186/bcr3340

Ejemplares similares